FA
BEAT

FDx Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

FDx Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-11,692
Closed -$84K – 1037
2014
Q2 		$84K Hold
11,692
– – 0.01% 964
2014
Q1 		$118K Buy
+11,692
New +$108K 0.01% 750

Other funds holding BEAT

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

FDx Advisors's BEAT Position: Q3 2014 in Review

FDx Advisors sold out of BioTelemetry, Inc. (BEAT) in Q3 2014, closing a stake of 11,692 shares — an estimated $84K sold.

FDx Advisors first reported a position in BEAT in Q1 2014 and held it in 2 quarters. The position peaked at $118K in Q1 2014. 85 funds tracked by Wall St. Rank hold BEAT as of Q3 2014.

  • FDx Advisors reported no remaining BioTelemetry, Inc. position as of Q3 2014 after selling out during the quarter.
  • FDx Advisors sold 11,692 BioTelemetry, Inc. shares in Q3 2014, an estimated $84K.
  • FDx Advisors first reported a position in BioTelemetry, Inc. in Q1 2014 and held it in 2 quarters.
  • FDx Advisors's BioTelemetry, Inc. position peaked at $118K in Q1 2014.
  • 85 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2014.

Based on FDx Advisors's 13F filing for Q3 2014, filed 17 Nov 2014.